U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H14N4O2
Molecular Weight 234.2545
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EPIRIZOLE

SMILES

COC1=CC(C)=NN1C2=NC(C)=CC(OC)=N2

InChI

InChIKey=RHAXSHUQNIEUEY-UHFFFAOYSA-N
InChI=1S/C11H14N4O2/c1-7-5-9(16-3)13-11(12-7)15-10(17-4)6-8(2)14-15/h5-6H,1-4H3

HIDE SMILES / InChI
Epirizole (also known as Mepirizole) is a nonsteroidal anti-inflammatory drug developed for the treatment of such conditions as chronic rheumatoid arthritis. Although the drug was tested in a clinical trial, its current status is unknown and is supposed to be discontinued. Epirizole is known to be a duodenal ulcerogen, and its effect is mediated by generation of ROS.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
0.8 μg/mL
200 mg single, oral
dose: 200 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
EPIRIZOLE serum
Homo sapiens
population: HEALTHY
age: UNKNOWN
sex: MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
600 mg 3 times / day multiple, oral
Highest studied dose
Dose: 600 mg, 3 times / day
Route: oral
Route: multiple
Dose: 600 mg, 3 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: FED
Sources:
Other AEs: Stomachache, Nausea...
Other AEs:
Stomachache
Nausea
Sources:
AEs

AEs

AESignificanceDosePopulation
Nausea
600 mg 3 times / day multiple, oral
Highest studied dose
Dose: 600 mg, 3 times / day
Route: oral
Route: multiple
Dose: 600 mg, 3 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: FED
Sources:
Stomachache
600 mg 3 times / day multiple, oral
Highest studied dose
Dose: 600 mg, 3 times / day
Route: oral
Route: multiple
Dose: 600 mg, 3 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: FED
Sources:
PubMed

PubMed

TitleDatePubMed
Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
2004
Synthesis, crystal structure, magnetic properties, and theoretical studies of [(Cu(mepirizole)Br)2(mu-OH)(mu-pz)] (mepirizole=4-methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidine; pz=pyrazolate), a novel mu-pyrazolato-mu-hydroxo-dibridged copper(II) complex.
2003-12-15
Study of the modifications caused by cisplatin, transplatin, and Pd(II) and Pt(II) mepirizole derivatives on pBR322 DNA by atomic force microscopy.
2002-10-01
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
EPIRIZOLE
INN   MART.   MI   USAN   WHO-DD  
USAN   INN  
Official Name English
MEBRON
Preferred Name English
EPIRIZOLE [MI]
Common Name English
EPIRIZOLE [JAN]
Common Name English
epirizole [INN]
Common Name English
EPIRIZOLE [USAN]
Common Name English
EPIRIZOLE [MART.]
Common Name English
DA-398
Code English
Epirizole [WHO-DD]
Common Name English
MEPIRIZOLE
Common Name English
METHOPYRIMAZOLE
Common Name English
PYRIMIDINE, 4-METHOXY-2-(5-METHOXY-3-METHYL-1H-PYRAZOL-1-YL)-6-METHYL-
Systematic Name English
4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine
Systematic Name English
2-(3-METHYL-5-METHOXY-1-PYRAZOLYL)-4-METHOXY-6-METHYL-PYRIMIDINE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C257
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
Code System Code Type Description
CAS
18694-40-1
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
NCI_THESAURUS
C76075
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
WIKIPEDIA
EPIRIZOLE
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
EVMPD
SUB13691MIG
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
MESH
D004840
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
INN
2929
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
ChEMBL
CHEMBL1411693
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
ECHA (EC/EINECS)
242-507-1
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
FDA UNII
3B46O2FH8I
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
MERCK INDEX
m4947
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY Merck Index
DRUG CENTRAL
1029
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
SMS_ID
100000078948
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID4045422
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
PUBCHEM
3242
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY
DRUG BANK
DB08991
Created by admin on Mon Mar 31 17:36:12 GMT 2025 , Edited by admin on Mon Mar 31 17:36:12 GMT 2025
PRIMARY